Five Arrows Managers
Five Arrows is the alternative assets arm of Rothschild & Co, founded in 2008 and headquartered in Paris, France. It manages over €31 billion in assets across corporate and secondary private equity, multi-manager funds, co-investments, and credit strategies, focusing on mid-market companies in Europe and North America.
Five Arrows Managers is a Paris buyout firm with €31M AUM, 38 active companies and 21 exits.
- ·8 exits in the last 5 years · consistent DPI cadence.
- ·Average hold across 21 realized deals: 6 years.
- ·Fund cadence: ~3Y between vintages · last raise 2025.
Sector breakdown
59 companiesGeography breakdown
12 geographiesKey facts
Recent exits
Five Arrows Managers sold Kpler to Sixth Street in 2026 after 4 years.
Five Arrows Managers sold Softway Medical to Bain Capital Europe in 2025 after 5 years.
Five Arrows Managers sold Harvest to TA Associates and Montagu Private Equity in 2024 after 5 years.
Five Arrows Managers sold CBA to Vivalto Partners and Amundi in 2023 after 5 years.
Coverage notes
5 funds tracked, 59 portfolio companies (38 active · 21 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Five Arrows Managers has raised, with its portfolio companies. Hand-checked from public filings.
Five Arrows Debt Partners IVPrivate Debt2025€2.4B3 assetsPrivate Debt2025 · 1yr€2.4B3–
Five Arrows Secondary Opportunities VISecondaries2025€2.0B1 assetsSecondaries2025 · 1yr€2.0B1–
Unrealized
1 held| Company | Entry |
|---|---|
| everii Group GmbH Software · Germany | 2025 |
Five Arrows Principal InvestmentsGrowth2024€1.3B32 assets19 exitsGrowth2024 · 2yr€1.3B3219
Unrealized
32 held| Company | Entry |
|---|---|
| A2mac1 Data & Analytics · France | 2017 |
| Agilio HealthTech · UK | 2024 |
| Alpina Group Financials · Netherlands | 2024 |
| Averhealth Business Services · US | 2019 |
| Blue Mountain HealthTech · US | 2025 |
| Bridgeway Benefit Technologies TMT · US | 2021 |
| Causeway SaaS · UK | 2021 |
| Centric Health Healthcare · Republic Of Ireland | 2024 |
| Everway EdTech · UK | 2024 |
| Expana TMT · UK | 2022 |
| GEDH TMT · France | 2022 |
| Hublo HealthTech · France | 2025 |
| iad Business Services · France | 2024 |
| Intact SaaS · Austria | 2024 |
| Intescia Telecom · France | 2022 |
| Juvare TMT · US | 2020 |
| Karnov Group TMT · Sweden | 2024 |
| KEV Group TMT · US | 2025 |
| Menix Group MedTech · France | 2017 |
| NetVendor PropTech · US | 2025 |
| Opus 2 TMT · UK | 2024 |
| Ovivio TMT · Netherlands | 2021 |
| Photonis Business Services · France | 2024 |
| Radiologie Holding Healthcare · Germany | 2019 |
| Rimes Data & Analytics · US | 2024 |
| RLDatix HealthTech · US | 2015 |
| Schivo Medical MedTech · Ireland | 2024 |
| Solifi SaaS · UK | 2024 |
| Solvares | Totalmobile SaaS · UK | 2024 |
| Springbrook Software · US | 2024 |
| Sygnature Discovery Pharma · UK | 2021 |
| Zenith American Solutions Business Services · US | 2024 |
Realized
19 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Autodata Group Business Services · UK | 2014 | 2017 | Trade Sale | Solera Holdings, Inc. | – |
| CBA TMT · France | 2018 | 2023 | Secondary | Vivalto Partners and Amundi | – |
| eDreams ODIGEO Business Services · Spain | 2010 | 2021 | Secondary | Institutional investors (public market) | – |
| Etanco Construction · France | 2011 | 2018 | Secondary | Intermediate Capital Group (ICG), alongside management | – |
| Forno d'Asolo Consumer · Italy | 2014 | 2018 | Secondary | BC Partners | – |
| Harvest Fintech · France | 2019 | 2024 | Secondary | TA Associates and Montagu Private Equity | – |
| Hygie31 Consumer · France | 2016 | 2022 | Secondary | Latour Capital | – |
| Kisimul Real Estate · UK | 2011 | 2017 | Secondary | Antin Infrastructure Partners | – |
| Les Petits Chaperons Rouges Education · France | 2010 | 2016 | Secondary | Eurazeo and Bpifrance | – |
| Les Petits Chaperons Rouges Education · France | 2010 | 2016 | Secondary | Eurazeo and Bpifrance | – |
| Les Petits Chaperons Rouges Business Services · France | 2010 | 2016 | Secondary | Eurazeo and Bpifrance | – |
| Munters Energy · Sweden | 2011 | 2017 | IPO | IPO (Nasdaq Stockholm) | – |
| Pirum Group Fintech · UK | 2015 | 2019 | Secondary | Bowmark Capital | – |
| Prosol (Grand Frais) Consumer · France | 2011 | 2017 | Secondary | Ardian | – |
| Prospitalia Group TMT · Germany | 2014 | 2018 | Secondary | Nordic Capital | – |
| Socotec Business Services · France | 2013 | 2019 | Secondary | Clayton, Dubilier & Rice | – |
| Softway Medical HealthTech · France | 2020 | 2025 | Secondary | Bain Capital Europe | – |
| The Binding Site MedTech · UK | 2011 | 2023 | Trade Sale | Thermo Fisher Scientific | – |
| The Stepping Stones Group Healthcare · US | 2017 | 2021 | Secondary | Leonard Green & Partners | – |
Five Arrows Growth CapitalGrowth2022€78M2 assets1 exitsGrowth2022 · 4yr€78M21
Five Arrows Direct LendingPrivate Debt2014€100M0 assets1 exitsPrivate Debt2014 · 12yr€100M01
Realized
1 exit| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Dominique Dutscher Healthcare · France | 2013 | 2020 | Secondary | LBO France | – |
About Five Arrows Managers
Five Arrows is the alternative assets arm of Rothschild & Co, founded in 2008 and headquartered in Paris with €31 billion of assets under management across corporate and secondary private equity, multi-manager funds, co-investments and credit strategies. The platform leverages the multi-century Rothschild banking heritage to provide diversified alternative asset management across multiple distinct strategy categories.
Investment thesis
Five Arrows deploys capital across complementary alternative strategies including corporate private equity (mid-market buyout and growth), secondary private equity (LP-led and GP-led secondary transactions), multi-manager funds (fund-of-funds positions), co-investments alongside lead sponsors, and credit strategies (private debt and credit secondaries). The multi-strategy mandate enables Five Arrows to provide institutional limited partners with diversified European alternative asset exposure.
Recent activity
Recent realised exits include Softway Medical (healthcare, 2025), Harvest (financials, 2024) and Menix Group (healthcare, 2024), reflecting strong distribution across the multi-strategy alternative platform. The platform tracks 3 funds tracked on GP Intel, 32 active portfolio companies and 21 realised exits across the broader Five Arrows alternative asset programme.
Frequently asked questions
- What investment strategy does Five Arrows Managers focus on?
- Five Arrows Managers focuses on Buyout, Growth strategies in the private equity space.
- How many portfolio companies does Five Arrows Managers have?
- Five Arrows Managers has 38 active portfolio companies and 21 completed exits and 5 funds tracked on GP Intel.
- Where is Five Arrows Managers headquartered?
- Five Arrows Managers is headquartered in Paris, France.
- What is Five Arrows Managers's assets under management?
- Five Arrows Managers manages approximately €31M in assets under management.
- When was Five Arrows Managers founded?
- Five Arrows Managers was founded in 2008.
- What sectors does Five Arrows Managers invest in?
- Five Arrows Managers invests across Healthcare, Business Services, Software.
- What are Five Arrows Managers's recent exits?
- Recent realized exits by Five Arrows Managers include: Kpler (2026) to Sixth Street; Softway Medical (2025) to Bain Capital Europe; Harvest (2024) to TA Associates and Montagu Private Equity; CBA (2023) to Vivalto Partners and Amundi; The Binding Site (2023) to Thermo Fisher Scientific; Hygie31 (2022) to Latour Capital; eDreams ODIGEO (2021) to Institutional investors (public market); The Stepping Stones Group (2021) to Leonard Green & Partners.
Similar firms
Other private equity firms tracked on GP Intel.